Medable Expands Adoption of Agentic AI in Clinical Development with Alveus Therapeutics – Business Wire

Medable has expanded its adoption of agentic AI technology in clinical development through a partnership with Alveus Therapeutics. The collaboration aims to integrate AI-driven automation into the clinical trial process to enhance efficiency and streamline operations.

Read Full Article →